Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

ChitogenX CEO highlights name change and augmented strategy following eventful second quarter

ChitogenX CEO highlights name change and augmented strategy following eventful second quarter

ChitogenX Inc (CSE:CHGX) Philippe Deschamps takes Proactive's Stephen Gunnion through milestones the reached in the second quarter of its financial year, most notably the change in its name to better reflects its expanded clinical and commercial opportunities, mission, values, and core competencies.

Another highlight of the quarter was the initiation of patients’ enrollment following completion of the first patient surgery in its US Phase I/II rotator cuff tear repair clinical trial, Deschamps added.

#ProactiveInvestors #ChitogenX #CSE

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK